Home/Filings/4/0001209191-18-033067
4//SEC Filing

Cooper Laurence James Neil 4

Accession 0001209191-18-033067

CIK 0001107421other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 5:11 PM ET

Size

4.9 KB

Accession

0001209191-18-033067

Insider Transaction Report

Form 4
Period: 2018-05-05
Cooper Laurence James Neil
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2018-05-05$4.41/sh123,333$543,8991,266,063 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001641506

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:11 PM ET
Size
4.9 KB